This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yaqi Cao: Innovator in JAK Inhibitor Development
Introduction
Yaqi Cao is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors. Her innovative work has led to the creation of a unique salt form and crystal form of a JAK inhibitor, showcasing her expertise in medicinal chemistry.
Latest Patents
Yaqi Cao holds a patent for the "Salt form and crystal form of JAK inhibitor, preparation method therefor, and use thereof." This invention provides a detailed description of a salt form and a crystal form of a JAK inhibitor, along with a preparation method and its applications. The patent includes an X-ray powder diffraction pattern of a crystal form A of the compound, which exhibits characteristic diffraction peaks at specific 2θ angles, demonstrating the uniqueness of her invention. She has 1 patent to her name.
Career Highlights
Yaqi Cao is associated with Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., where she has been instrumental in advancing research and development in biopharmaceuticals. Her work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications in treating various diseases.
Collaborations
Yaqi Cao has collaborated with notable colleagues, including Ming Cheng and Junen Sun. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes in their field.
Conclusion
Yaqi Cao's contributions to the development of JAK inhibitors exemplify her dedication to advancing pharmaceutical science. Her innovative patent and collaborative efforts highlight her role as a key figure in the biopharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile